BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 25062720)

  • 21. Impact of posaconazole prophylaxis and antifungal treatment on BAL GM performance in hematology malignancy patients with febrile neutropenia: a real life experience.
    Acet-Öztürk NA; Ömer-Topçu D; Vurat Acar K; Aydın-Güçlü Ö; Pınar İE; Demirdöğen E; Görek-Dilektaşlı A; Kazak E; Özkocaman V; Ursavas A; Özkalemkaş F; Ener B; Ali R; Akalın H
    Eur J Clin Microbiol Infect Dis; 2024 Jan; 43(1):33-43. PubMed ID: 37910269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies.
    Bergeron A; Belle A; Sulahian A; Lacroix C; Chevret S; Raffoux E; Arnulf B; Socié G; Ribaud P; Tazi A
    Chest; 2010 Feb; 137(2):410-5. PubMed ID: 19801584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Park SY; Lee SO; Choi SH; Sung H; Kim MN; Choi CM; Hong SB; Oh YM; Shim TS; Koh Y; Kim YS; Woo JH; Kim SH
    J Infect; 2010 Dec; 61(6):492-8. PubMed ID: 20833201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study.
    Hardak E; Fuchs E; Leskes H; Geffen Y; Zuckerman T; Oren I
    Int J Infect Dis; 2019 Jun; 83():20-25. PubMed ID: 30926540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic yield of bronchoscopic sampling in febrile neutropenic patients with pulmonary infiltrate and haematological disorders.
    Seneviratna A; O'Carroll M; Lewis CA; Milne D
    Intern Med J; 2012 May; 42(5):536-41. PubMed ID: 22150957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples.
    Reinwald M; Spiess B; Heinz WJ; Vehreschild JJ; Lass-Flörl C; Kiehl M; Schultheis B; Krause SW; Wolf HH; Bertz H; Maschmeyer G; Hofmann WK; Buchheidt D
    Eur J Haematol; 2012 Aug; 89(2):120-7. PubMed ID: 22650156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.
    Hadrich I; Makni F; Cheikhrouhou F; Neji S; Amouri I; Sellami H; Trabelsi H; Bellaaj H; Elloumi M; Ayadi A
    Pathol Biol (Paris); 2012 Dec; 60(6):357-61. PubMed ID: 22154334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts.
    Nguyen MH; Jaber R; Leather HL; Wingard JR; Staley B; Wheat LJ; Cline CL; Baz M; Rand KH; Clancy CJ
    J Clin Microbiol; 2007 Sep; 45(9):2787-92. PubMed ID: 17596367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of volume of instillate on the diagnostic utility of bronchoalveolar lavage galactomannan in patients with suspected chronic pulmonary aspergillosis-A pilot study.
    Ajayababu A; Singh G; Meena VP; Upadhyay AD; Rana B; Sethi P; Prakash B; Singh A; Vyas S; Sinha S; Xess I; Wig N; Kabra SK; Ray A
    Mycoses; 2024 Jan; 67(1):e13695. PubMed ID: 38282361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of bronchoalveolar lavage samples in immunosuppressed patients with suspected pneumonia: analysis of a protocol.
    Vélez L; Correa LT; Maya MA; Mejía P; Ortega J; Bedoya V; Ortega H
    Respir Med; 2007 Oct; 101(10):2160-7. PubMed ID: 17629473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.
    Prattes J; Lackner M; Eigl S; Reischies F; Raggam RB; Koidl C; Flick H; Wurm R; Palfner M; Wölfler A; Neumeister P; Thornton CR; Krause R; Lass-Flörl C; Hoenigl M
    Mycoses; 2015 Aug; 58(8):461-9. PubMed ID: 26103209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical usefulness of bronchoalveolar lavage in heart transplant recipients with suspected lower respiratory tract infection.
    Lehto JT; Anttila VJ; Lommi J; Nieminen MS; Harjula A; Taskinen E; Tukiainen P; Halme M
    J Heart Lung Transplant; 2004 May; 23(5):570-6. PubMed ID: 15135373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bronchoalveolar lavage fluid galactomannan detection for diagnosis of invasive pulmonary aspergillosis in chronic obstructive pulmonary disease.
    Zhang XB; Chen GP; Lin QC; Lin X; Zhang HY; Wang JH
    Med Mycol; 2013 Oct; 51(7):688-95. PubMed ID: 23527739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspergillus galactomannan detection in exhaled breath condensate compared to bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in immunocompromised patients.
    Bhimji A; Bhaskaran A; Singer LG; Kumar D; Humar A; Pavan R; Lipton J; Kuruvilla J; Schuh A; Yee K; Minden MD; Schimmer A; Rotstein C; Keshavjee S; Mazzulli T; Husain S
    Clin Microbiol Infect; 2018 Jun; 24(6):640-645. PubMed ID: 28970160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbiologic yield of bronchoalveolar lavage specimens from stem cell transplant recipients.
    Sakata KK; Klassen CL; Bollin KB; Grys TE; Slack JL; Wesselius LJ; Vikram HR
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28218980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of flexible bronchoscopy in the evaluation of pulmonary infiltrates in the hematopoietic stem cell transplant population -- a single center fourteen year experience.
    Gilbert CR; Lerner A; Baram M; Awsare BK
    Arch Bronconeumol; 2013 May; 49(5):189-95. PubMed ID: 23455477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using Interleukin 6 and 8 in Blood and Bronchoalveolar Lavage Fluid to Predict Survival in Hematological Malignancy Patients With Suspected Pulmonary Mold Infection.
    Rawlings SA; Heldt S; Prattes J; Eigl S; Jenks JD; Flick H; Rabensteiner J; Prüller F; Wölfler A; Neumeister P; Strohmaier H; Krause R; Hoenigl M
    Front Immunol; 2019; 10():1798. PubMed ID: 31428097
    [No Abstract]   [Full Text] [Related]  

  • 39. Pulmonary infiltrates in patients with haematologic malignancies: transbronchial lung biopsy increases the diagnostic yield with respect to neoplastic infiltrates and toxic pneumonitis.
    Mulabecirovic A; Gaulhofer P; Auner HW; Popper H; Krause R; Hesse C; Sill H
    Ann Hematol; 2004 Jul; 83(7):420-2. PubMed ID: 15133629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases.
    Maertens J; Maertens V; Theunissen K; Meersseman W; Meersseman P; Meers S; Verbeken E; Verhoef G; Van Eldere J; Lagrou K
    Clin Infect Dis; 2009 Dec; 49(11):1688-93. PubMed ID: 19886801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.